​

ADC Therapeutics SA (ADCT) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

ADC Therapeutics SA Revenue Highlights

Latest Revenue (Y)

$69.56M

Latest Revenue (Q)

$17.41M

Main Segment (Y)

Product

Main Geography (Y)

UNITED STATES

ADC Therapeutics SA Revenue by Period

ADC Therapeutics SA Revenue by Year

DateRevenueChange
2023-12-31$69.56M-66.86%
2022-12-31$209.91M518.89%
2021-12-31$33.92M100.00%
2020-12-31--100.00%
2019-12-31$2.34M105.26%
2018-12-31$1.14M-36.77%
2017-12-31$1.80M-

ADC Therapeutics SA generated $69.56M in revenue during NA 2023, up -66.86% compared to the previous quarter, and up 6101.58% compared to the same period a year ago.

ADC Therapeutics SA Revenue by Quarter

DateRevenueChange
2024-06-30$17.41M-3.56%
2024-03-31$18.05M7.52%
2023-12-31$16.79M15.85%
2023-09-30$14.49M-24.84%
2023-06-30$19.28M1.53%
2023-03-31$18.99M-72.79%
2022-12-31$69.80M-8.55%
2022-09-30$76.32M341.39%
2022-06-30$17.29M-62.81%
2022-03-31$46.50M173.36%
2021-12-31$17.01M29.38%
2021-09-30$13.15M249.65%
2021-06-30$3.76M100.00%
2021-03-31--100.00%
2020-12-31$51.90M100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30--100.00%
2019-06-30$1.96M67.69%
2019-03-31$1.17M354.37%
2018-12-31$257.50K-
2018-09-30$257.50K-17.60%
2018-06-30$312.50K-
2018-03-31$312.50K-

ADC Therapeutics SA generated $17.41M in revenue during Q2 2024, up -3.56% compared to the previous quarter, and up 91.67% compared to the same period a year ago.

ADC Therapeutics SA Revenue Breakdown

ADC Therapeutics SA Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21
Royalty Revenue$498.00K--
Product$69.06M--
License Revenues---
Contract Revenue-$135.00M-
Product Revenue-$74.91M$33.92M

ADC Therapeutics SA's latest annual revenue breakdown by segment (product or service), as of Dec 23: Product (99.28%), and Royalty Revenue (0.72%).

Quarterly Revenue by Product

Product/ServiceSep 24Mar 24Dec 23Jun 23Mar 23Sep 22Jun 22Mar 22
Product$18.02M$17.85M------
Royalty Revenue$448.00K$205.00K$373.00K$86.00K$39.00K---
Product Revenue, Net---$19.20M$18.95M$21.32M$17.29M$16.50M
License Revenue-----$55.00M-$30.00M

ADC Therapeutics SA's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Product (97.57%), and Royalty Revenue (2.43%).

ADC Therapeutics SA Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23
UNITED STATES$69.06M
EMEA$498.00K
JAPAN-

ADC Therapeutics SA's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (99.28%), and EMEA (0.72%).

Quarterly Revenue by Country

CountrySep 24Mar 24Dec 23Jun 23Mar 23
UNITED STATES$18.02M$17.85M$30.91M$19.20M$18.95M
EMEA$448.00K$205.00K$373.00K$86.00K$39.00K
JAPAN-----

ADC Therapeutics SA's latest quarterly revenue breakdown by geography, as of Sep 24: UNITED STATES (97.57%), and EMEA (2.43%).

ADC Therapeutics SA Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
RAREUltragenyx Pharmaceutical$434.25M$147.03M
ALECAlector$97.06M$15.08M
ARVNArvinas$78.50M$102.40M
ADCTADC Therapeutics SA$69.56M$17.41M
PTGXProtagonist Therapeutics$60.00M$4.67M
AADIAadi Bioscience$24.35M$7.21M
RVMDRevolution Medicines$11.58M-
RNAAvidity Biosciences$9.56M$2.04M
STOKStoke Therapeutics$8.78M$4.89M
GBIOGeneration Bio$5.90M$4.09M
CRNXCrinetics Pharmaceuticals$4.01M-
IPSCCentury Therapeutics$2.23M$791.00K
DSGNDesign Therapeutics--
ALVRAlloVir--
ALXOALX Oncology--
BDTXBlack Diamond Therapeutics--
KURAKura Oncology--
PASGPassage Bio--
AKROAkero Therapeutics--

ADCT Revenue FAQ

What is ADC Therapeutics SA’s yearly revenue?

ADC Therapeutics SA's yearly revenue for 2023 was $69.56M, representing a decrease of -66.86% compared to 2022. The company's yearly revenue for 2022 was $209.91M, representing an increase of 518.89% compared to 2021. ADCT's yearly revenue for 2021 was $33.92M, representing an increase of 100.00% compared to 2020.

What is ADC Therapeutics SA’s quarterly revenue?

ADC Therapeutics SA's quarterly revenue for Q2 2024 was $17.41M, a -3.56% decrease from the previous quarter (Q1 2024), and a -9.71% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $18.05M, a 7.52% increase from the previous quarter (Q4 2023), and a -4.94% decrease year-over-year (Q1 2023). ADCT's quarterly revenue for Q4 2023 was $16.79M, a 15.85% increase from the previous quarter (Q3 2023), and a -75.94% decrease year-over-year (Q4 2022).

What is ADC Therapeutics SA’s revenue growth rate?

ADC Therapeutics SA's revenue growth rate for the last 3 years (2021-2023) was 105.08%, and for the last 5 years (2019-2023) was 2872.56%.

What are ADC Therapeutics SA’s revenue streams?

ADC Therapeutics SA's revenue streams in c 23 are Royalty Revenue, and Product. Royalty Revenue generated $498K in revenue, accounting 0.72% of the company's total revenue Product generated $69.06M in revenue, accounting 99.28% of the company's total revenue

What is ADC Therapeutics SA’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of ADC Therapeutics SA was Product. This segment made a revenue of $69.06M, representing 99.28% of the company's total revenue.